Market Executive Summary

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.

The global Biologics market is projected to grow from US$ 110030 million in 2024 to US$ 149290 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.

In terms of production side, this report researches the Biologics production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Biologics by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:

This report presents an overview of global market for Biologics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. 

This report researches the key producers of Biologics, also provides the consumption of main regions and countries. The upcoming market potential for Biologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Biologics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion, Addgene, Amgen, Abbvie Inc., Sanofi and Pfizer Inc., etc.

Global Biologics Companies Covered

Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion, Addgene, Amgen, Abbvie Inc., Sanofi, Pfizer Inc., Merck & Co. Inc., Novo Nordisk A/S, Johnson & Johnson Services Inc.

Global Biologics Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Biologics Market, Segment by Type

Monoclonal Antibodies

Vaccines

Recombinant Proteins

Antisense

RNAi

Global Biologics Market, Segment by Application

Infectious Diseases

Oncology

Immunology

Autoimmune Diseases

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Biologics production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Biologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.